Article ID Journal Published Year Pages File Type
6192942 Journal of Thoracic Oncology 2014 10 Pages PDF
Abstract
These results further support the association between inflammatory markers and lung cancer outcome and suggest that a combined serum IL-6/IL-8 classifier could be a useful tool for guiding therapeutic decisions in patients with stage I lung cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Authors
, , , , , ,